Current Opinion in Nephrology and Hypertension

Article	Citations
Dual organ transplantation: Pancreas and Liver in the kidney axis	38
Population Health Strategies for Health Equity in Chronic Kidney Disease Management: Retraction	38
Emerging strategies to reduce kidney function decline and improve cardiovascular outcomes	26
Editorial introductions	26
Maximizing opportunities for kidney transplantation in older adults	25
Does cooled dialysate still have a role in reducing intradialytic stress? Implications of the MyTEMP trial	24
Interferon gamma in the pathogenesis of hypertension − recent insights	22
Effect of the allelic background on the phenotype of primary hyperoxaluria type I	21
The impact of conflicts on patients with chronic kidney disease	19
The coronavirus disease 2019 pandemic: the disruptor that maintenance dialysis never anticipated	19
Barriers to home dialysis and kidney transplantation for socially disadvantaged individuals	18
Tackling the intersectoral challenges in kidney diseases and transplantation: shared decision and realistic care for advanced diagnostic and therapeutic modalities for kidney diseases and transplantat	18
International equity in access to home dialysis	17
Editorial introduction	17
Has the time come for age-adapted glomerular filtration rate criteria to define chronic kidney disease: how soon is now?	16
Modern indications for referral for kidney and pancreas transplantation	16
Prediction models for earlier stages of chronic kidney disease	16
Renal denervation for the treatment of hypertension and kidney disease	15
Safety of SGLT2i with regard to bone and mineral metabolism in patients with CKD	15
Staying home when peritoneal dialysis ends: the integrated home dialysis approach	13
Plant-based diets for kidney disease prevention and treatment	13
Recent advances in peritoneal dialysis catheter placement: the association between method of insertion, operator, and prior abdominal surgery and outcomes	13
Bringing the end-stage kidney disease life plan home	13
The race coefficient in glomerular filtration rate-estimating equations and its removal	13
Dialysis initiation for patients with decompensated cirrhosis when liver transplant is unlikely	12

Calcium-binding protein 39 in with-no-lysine kinase signaling and the modulation of renal tubular transport	12
Skeletal parathyroid hormone hyporesponsiveness: a neglected, but clinically relevant reality in chronic kidney disease	12
Calcium phosphate microcrystallopathy as a paradigm of chronic kidney disease progression	11
A basic solution for a complex problem: does treatment of metabolic acidosis slow CKD progression?	11
Editorial: The evolution of my personal conflict of interest: I am part of an ‘ineligible company’	11
Sodium phosphate cotransporter 2a inhibitors: potential therapeutic uses	11
Editorial: One size does not fit all: moving toward individualized therapy	11
Synergistic susceptibility to environmental lead toxicity in chronic kidney disease	11
Built environment and chronic kidney disease: current state and future directions	11
Bringing medical education “home”: the university health network and St. Michael's hospital home dialysis fellowship	10
Understanding renal phosphate handling: unfinished business	10
Which patients with CKD will benefit from genomic sequencing? Synthesizing progress to illuminate the future	10
Complement detection in kidney biopsies – utility and challenges	10
Renal effects of cullin 3 mutations causing familial hyperkalemic hypertension	9
Editorial introductions	9
Editorial: Advancements in the management of kidney disease and electrolyte derangements	9
Lipocalin-2: a novel link between the injured kidney and the bone	9
A guide for program development of environmentally sustainable kidney care	9
A current update of the development of Chimeric Antigen Receptor T-cell therapy and kidney disease	9
Combination therapy with kidney protective therapies: optimizing the benefits?	9
Cancer drugs and acute kidney injury: new therapies and new challenges	9
Dietary protein intake and plant-dominant diets to mitigate risk of allograft dysfunction progression in kidney transplant recipients	9
When the earth shakes unexpectedly: impact on nephrology services and patients	8
Automation and innovation in home hemodialysis machines	8
Deep learning applications for kidney histology analysis	8
The current therapeutic approach for anaemia after kidney transplant	8
Climate change and kidney stones	8
HIV-associated kidney disease: the changing spectrum and treatment priorities	8
Glucagon-like peptide-1 receptor agonists to improve cardiorenal outcomes: data from FLOW and beyond	8
Editorial: Innovations in multimodal and integrated approaches in kidney care and renal transplantation	8
Editorial introductions	8
Impact of intensive blood pressure control on kidney outcomes	8
Recent updates in kidney risk prediction modeling: novel approaches and earlier outcomes	8
Editorial introductions	7
Evolving thresholds for the diagnosis of acute T cell mediated rejection	7
New insights into renal calcium-sensing receptor activation	7
Hypernatremia in the intensive care unit	7
Mitochondrial bioenergetics: coupling of transport to tubular mitochondrial metabolism	7
Recent advances in treatment options for kidney disease	7
Editorial introductions	7
Renal osteodystrophy: something old, something new, something needed	7
New and old approaches to nutritional management of acute and chronic glomerulonephritis	7
Prospects for gene therapy in polycystic kidney disease	7
Epithelial Na+ channel and the glycocalyx: a sweet and salty relationship for arterial shear stress sensing	7
Editorial introduction	7
Building kidney organoids from pluripotent stem cells	6
Multimodal approaches for inequality in kidney care: turning social determinants of health into opportunities	6
Prevention of postoperative acute kidney injury: insights from recent clinical trials	6
Sex differences in renal electrolyte transport	6
Vaccination in kidney disease: what did we learn from COVID-19 pandemic	6

Contemporary risk prediction models in chronic kidney disease: when less is more	6
Proximal tubule responses to injury: interrogation by single-cell transcriptomics	6
Enhancing accuracy and adherence in blood pressure monitoring in living kidney donation: implementing technologies to overcome challenges	6
C3 glomerulopathy: advancements in diagnostics and therapeutics	6
New therapeutic perspectives for vascular and valvular calcifications in chronic kidney disease	6
Screening for chronic kidney disease: change of perspective and novel developments	6
Evolving indications and management patterns in heart – kidney transplantation	6
Renal denervation: recent developments in clinical and preclinical research	6
Rare genetic disorders that impair parathyroid hormone synthesis, secretion, or bioactivity provide insights into the diagnostic utility of different parathyroid hormone assays	6
Frailty, multimorbidity and sarcopaenia in haemodialysis patients	5
The genetics of cystinuria – an update and critical reevaluation	5
New guidelines and therapeutic updates for the management of lupus nephritis	5
Staff-assisted peritoneal dialysis in the United States: from evidence to national adoption	5
Effects of aging on chronic kidney disease mineral and bone disorder	5
An update on corticosteroid treatment for IgA nephropathy	5
Adverse effects during treatment with renin–angiotensin–aldosterone system inhibitors; should we stay or should we stop?	5
Editorial: Novel therapeutic approaches in chronic kidney disease and kidney transplantation: the draw of evolving integrated multimodal approaches in the targeted therapy era	5
Exercise as a therapeutic intervention in chronic kidney disease: are we nearly there yet?	5
New therapeutics for primary hyperoxaluria type 1	5
Peritoneal dialysis and heart failure	5
Novel agents for treating IgA nephropathy	5
Fibroblast growth factor 23 as a risk factor for incident diabetes	5
Chronic kidney disease and sex dimorphism	5
Therapies in autosomal dominant polycystic kidney disease: beyond tolvaptan	5
Novel approaches in antihypertensive pharmacotherapeutics	5
The changing trajectory of diabetic kidney disease	5
Population health strategies for health equity in chronic kidney disease management	5
Cystatin C should be routinely available for estimating kidney function	5
Targeting inflammation in hypertension	5
Editorial introductions	4
Centering marginalized voices in advocacy for equitable policy change in kidney disease	4
Factors that lead to dialysis as the preferred treatment modality for patients with chronic kidney disease	4
Home dialysis: there's no place like home	4
Indications for and results of renal autotransplantation	4
Insights into proliferative glomerulonephritis with monoclonal immunoglobulin deposits – is it really monoclonal or not?	4
Updates on renal phosphate transport	4
Climate change and its influence in nephron mass	4
Electrolytes disturbances in cancer patients	4
Editorial introductions	4
Mitochondrial deacetylase Sirt3 in vascular dysfunction and hypertension	4
Progress in the management of patients with diabetes and chronic kidney disease	4
Persistent hyperparathyroidism in long-term kidney transplantation: time to consider a less aggressive approach	4
Editorial introductions	4
Novel insights in the regulation of intercalated cell differentiation	4
The promise of artificial intelligence for kidney pathophysiology	4
Phosphate sensing in health and disease	4
Glomerular filtration rate and sexual dimorphism: lessons from animal and human studies	4
Climate crisis and nephrology: a review of climate change's impact on nephrology and how to combat it	4
The role of osteopontin in chronic kidney disease-mineral bone disorder	4
The potential of artificial intelligence-based applications in kidney pathology	4
WNK1 in the kidney	4
The role of calprotectin in vascular calcification	4
Editorial: Narrow the gap, build a bridge: an inspirational approach to chronic kidney disease–mineral and bone disorder	4
Use of water in dialysis and its impact on the environment	4
Editorial introductions	4
The times they are K+-changin’: bringing the potassium curriculum out of the 20th century	4
Pruritus in chronic kidney disease	4
Updated diagnostic and therapeutic management for membranous nephropathy	4
Literature review: are NSAIDs harmful and is acetaminophen well tolerated?	4
Mendelian randomization and the association of fibroblast growth factor-23 with heart failure with preserved ejection fraction	4
Agents to treat osteoporosis in chronic kidney disease	4
Fifty years of basic and clinical renal stone research: have we achieved major breakthroughs? A debate	4
COVID-19 in patients with glomerular disease	4
Role of inwardly rectifying K+ channel 5.1 (Kir5.1) in the regulation of renal membrane transport	4
Postnatal renal tubule development: roles of tubular flow and flux	4
Management of antineutrophil cytoplasmic antibody-associated vasculitis: a changing tide	4
Implications of climate change on acute kidney injury	4
Uromodulin: more than a marker for chronic kidney disease progression	3
Do not forget about transplant patients during disasters	3
Revisiting the relationship between (Pro)Renin receptor and the intrarenal RAS: focus on the soluble receptor	3
Challenges in standardizing preimplantation kidney biopsy assessments and the potential of AI-Driven solutions	3
Skin autofluorescence as tool for cardiovascular and diabetes risk prediction	3
Kidney health and function with left ventricular assist devices	3
Role of artificial intelligence in the diagnosis and management of kidney disease: applications to chronic kidney disease and acute kidney injury	3
Community acquired and hospital acquired AKI - two diseases divided by a common definition	3
Applications of cardiac biomarkers in chronic kidney disease	3
Contribution of phosphate and FGF23 to CKD progression	3
Editorial introductions	3
Lysine and salt-sensitive hypertension	3
Recent advances in the understanding of the peritoneal membrane	3

Justifying access to kidney care in low resource and humanitarian settings	3
Novel pharmacological interventions for diabetic kidney disease	3
Editorial introductions	3
Artificial intelligence in kidney disease and dialysis: from data mining to clinical impact	3
Social and humanitarian issues in nephrology and hypertension	3
Challenges and advances in the management of antineutrophil cytoplasmic antibody vasculitis in 2025	3
Targeting aldosterone to improve cardiorenal outcomes: from nonsteroidal mineralocorticoid receptor antagonists to aldosterone synthase inhibitors	3
Chronic kidney disease with unknown cause across the global spectrum	3
Oh, My Gut! New insights on the role of the gastrointestinal tract and the gut microbiome in chronic kidney disease-mineral and bone disorder	3
Biopsy-based transcriptomics in the diagnosis of kidney transplant rejection	3
The obesity and lipid paradoxes in chronic kidney disease: mechanisms, interventions, and future directions	3
Heating up: climate change and the threat to human health	3
Cellular and molecular interrogation of kidney biopsy specimens	3
Fibroblast growth factor 23, klotho and heparin	3
Diagnostic and therapeutic challenges in implementing hypertension management after kidney transplantation	3
Mitochondrial DNA – novel mechanisms of kidney damage and potential biomarker	3
Let's stop talking about ‘citrate toxicity’	3
APOL1 nephropathy – a population genetics success story	3
APOL1-associated kidney disease: modulators of the genotype-phenotype relationship	3
The climate impact of dialysis	2
Type 4 renal tubular acidosis and uric acid nephrolithiasis: two faces of the same coin?	2
Can chronic kidney disease lead to chronic heart failure, and does worsening chronic heart failure lead to chronic kidney disease progression	2
SLC26A1 directs sulfate homeostasis in health and disease	2
The genetic spectrum of Gitelman(-like) syndromes	2
Quality of life in people with chronic kidney disease: focusing on modifiable risk factors	2
Prospective collagen IVα345 therapies for Alport syndrome	2
Vasopressin, protein metabolism, and water conservation	2
The impact of chronic kidney disease on cognitive function	2
The TMEM16A channel as a potential therapeutic target in vascular disease	2
Editorial introductions	2
Citrate in autosomal dominant polycystic kidney disease: biomarker or therapeutic agent?	2
Optimizing renin–angiotensin–aldosterone inhibition in advanced chronic kidney disease: balancing benefits and risks	2
Immune checkpoint inhibitors and kidney disease	2
Harm! foul! How acute kidney injury SHReDDs patient futures	2
Practicing health equity in involuntary discharges to overcome disparities in dialysis and kidney patient care	2
A review of the AURORA and BLISS trials: will it revolutionize the treatment of lupus nephritis?	2
Moving beyond the syndrome: how can acute kidney injury phenotypes help?	2
Gene therapy for kidney disease: targeting cystinuria	2
The cardiovascular unphysiology of thrice weekly hemodialysis	2
Enabling flourishing: novel approaches in palliative medicine for children with advanced kidney disease	2
Novel indications for referral and care for simultaneous liver kidney transplant recipients	2
Kidney function assessment in the geriatric population	2
Hypertension in Pregnancy: What We Now Know	2
Treatment potential in APOL1-associated nephropathy	2
Metabolic dysfunction associated steatotic liver and kidney stones: what is going on?	2
Back to the future: a review of peritoneal dialysis for acute kidney injury	2